MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ygyno.2018.04.009

Медицинская библиотека · Gynecologic oncology · 2018

Postoperative chemotherapy for node-positive cervical cancer: Results of a multicenter phase II trial (JGOG1067).

Matoda Maki, Takeshima Nobuhiro, Michimae Hirofumi, Iwata Takashi, Yokota Harushige, Torii Yutaka, Yamamoto Yorito, Takehara Kazuhiro, Nishio Shin, Takano Hirokuni, Mizuno Mika, Takahashi Yoshiyuki, Takei Yuji, Hasegawa Tetsuya, Mikami Mikio, Enomoto Takayuki, Aoki Daisuke, Sugiyama Toru

Клиническое исследование II фазыСтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

OBJECTIVE

This multicenter phase II Japanese Gynecologic Oncology Group study (JGOG1067) was designed to evaluate the efficacy and safety of postoperative chemotherapy in patients with node-positive cervical cancer.

METHODS

Patients with stage IB-IIA squamous cervical cancer who underwent radical hysterectomy and were confirmed to have pelvic lymph node metastasis were eligible for this study. The patients postoperatively received irinotecan (CPT-11; 60mg/m2 intravenously on days 1 and 8) and nedaplatin (NDP; 80mg/m2 intravenously on day 1). Chemotherapy administration commenced within 6weeks after surgery and was repeated every 28days for up to 5cycles. The primary endpoint of this study was the 2-year recurrence-free survival (RFS) rate. The secondary endpoints were the 5-year overall survival (OS) rate, 5-year RFS rate, and adverse events such as complications of chemotherapy and lower-limb edema.

RESULTS

Sixty-two patients were analyzed according to our protocol, among whom 55 (88.7%) completed 5cycles of scheduled treatment. The median follow-up period was 66.1months (range, 16.8-96.6months). The 2-year and 5-year RFS rates were 87.1% (95% confidence interval [CI]: 75.9-99.3) and 77.2% (95% CI: 64.5-85.8), respectively. Fourteen patients (22.5%) experienced recurrence during the follow-up period, 8 of whom died of the disease. The 5-year OS rate in this study was 86.5% (95% CI: 74.8-93.0). Only 9.7% of the patients experienced lymphedema in their legs.

CONCLUSION

Postoperative chemotherapy without radiotherapy was found to be very effective in high-risk patients with node-positive cervical cancer.

Для цитирования: Matoda Maki, Takeshima Nobuhiro, Michimae Hirofumi, Iwata Takashi, Yokota Harushige, Torii Yutaka, Yamamoto Yorito, Takehara Kazuhiro, Nishio Shin, Takano Hirokuni, Mizuno Mika, Takahashi Yoshiyuki, Takei Yuji, Hasegawa Tetsuya, Mikami Mikio, Enomoto Takayuki, Aoki Daisuke, Sugiyama Toru. Postoperative chemotherapy for node-positive cervical cancer: Results of a multicenter phase II trial (JGOG1067).. Gynecologic oncology. 2018. DOI: 10.1016/j.ygyno.2018.04.009.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.